Virological aspects of Epstein-Barr virus infections

Nobuko Yamashita, Hiroshi Kimura, Tsuneo Morishima

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV) is usually maintained in an asymptomatic and latent form by the host immune system, and primarily by EBV-specific cytotoxic T cells (CTLs). However, EBV has been linked to several refractory diseases such as EBV-associated hemophagocytic syndrome (EBV-AHS) and chronic active EBV infection (CAEBV). In these ectopic diseases, EBV infects T/NK cells, causing severe immunodeficiency with a very high EBV load. In recent years, the laboratory procedure to assess these types of EBV infections has been improved. In particular, real-time polymerase chain reaction (PCR) has been used to quantify the EBV load, and the MHC: peptide tetramer assay has been used to quantitate EBV-specific CTLs; these tests have been employed for the management of the illnesses associated with EBV infection. Here, we have reviewed the recent progress in the clinical application of these assays. The pathogenesis of EBV-infected T/NK cells, and the host immune response to infection, including the roles carried out by innate immunity and inflammatory cytokines, are likely to be revealed in the future. Copyright

Original languageEnglish
Pages (from-to)239-246
Number of pages8
JournalActa Medica Okayama
Volume59
Issue number6
Publication statusPublished - Dec 2005

Fingerprint

Epstein-Barr Virus Infections
Human Herpesvirus 4
Viruses
Natural Killer Cells
T-cells
T-Lymphocytes
Hemophagocytic Lymphohistiocytosis
Assays
Innate Immunity
Real-Time Polymerase Chain Reaction
Immune system
Immune System
Polymerase chain reaction
Refractory materials
Cytokines
Peptides

Keywords

  • Chronic active Epstein-Barr virus infection
  • Epstein-Barr virus-associated hemophagocytic syndrome
  • Real-time PCR
  • Tetramer

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yamashita, N., Kimura, H., & Morishima, T. (2005). Virological aspects of Epstein-Barr virus infections. Acta Medica Okayama, 59(6), 239-246.

Virological aspects of Epstein-Barr virus infections. / Yamashita, Nobuko; Kimura, Hiroshi; Morishima, Tsuneo.

In: Acta Medica Okayama, Vol. 59, No. 6, 12.2005, p. 239-246.

Research output: Contribution to journalArticle

Yamashita, N, Kimura, H & Morishima, T 2005, 'Virological aspects of Epstein-Barr virus infections', Acta Medica Okayama, vol. 59, no. 6, pp. 239-246.
Yamashita, Nobuko ; Kimura, Hiroshi ; Morishima, Tsuneo. / Virological aspects of Epstein-Barr virus infections. In: Acta Medica Okayama. 2005 ; Vol. 59, No. 6. pp. 239-246.
@article{cc6702915cd34adf92943f80e6ac6a49,
title = "Virological aspects of Epstein-Barr virus infections",
abstract = "Epstein-Barr virus (EBV) is usually maintained in an asymptomatic and latent form by the host immune system, and primarily by EBV-specific cytotoxic T cells (CTLs). However, EBV has been linked to several refractory diseases such as EBV-associated hemophagocytic syndrome (EBV-AHS) and chronic active EBV infection (CAEBV). In these ectopic diseases, EBV infects T/NK cells, causing severe immunodeficiency with a very high EBV load. In recent years, the laboratory procedure to assess these types of EBV infections has been improved. In particular, real-time polymerase chain reaction (PCR) has been used to quantify the EBV load, and the MHC: peptide tetramer assay has been used to quantitate EBV-specific CTLs; these tests have been employed for the management of the illnesses associated with EBV infection. Here, we have reviewed the recent progress in the clinical application of these assays. The pathogenesis of EBV-infected T/NK cells, and the host immune response to infection, including the roles carried out by innate immunity and inflammatory cytokines, are likely to be revealed in the future. Copyright",
keywords = "Chronic active Epstein-Barr virus infection, Epstein-Barr virus-associated hemophagocytic syndrome, Real-time PCR, Tetramer",
author = "Nobuko Yamashita and Hiroshi Kimura and Tsuneo Morishima",
year = "2005",
month = "12",
language = "English",
volume = "59",
pages = "239--246",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "6",

}

TY - JOUR

T1 - Virological aspects of Epstein-Barr virus infections

AU - Yamashita, Nobuko

AU - Kimura, Hiroshi

AU - Morishima, Tsuneo

PY - 2005/12

Y1 - 2005/12

N2 - Epstein-Barr virus (EBV) is usually maintained in an asymptomatic and latent form by the host immune system, and primarily by EBV-specific cytotoxic T cells (CTLs). However, EBV has been linked to several refractory diseases such as EBV-associated hemophagocytic syndrome (EBV-AHS) and chronic active EBV infection (CAEBV). In these ectopic diseases, EBV infects T/NK cells, causing severe immunodeficiency with a very high EBV load. In recent years, the laboratory procedure to assess these types of EBV infections has been improved. In particular, real-time polymerase chain reaction (PCR) has been used to quantify the EBV load, and the MHC: peptide tetramer assay has been used to quantitate EBV-specific CTLs; these tests have been employed for the management of the illnesses associated with EBV infection. Here, we have reviewed the recent progress in the clinical application of these assays. The pathogenesis of EBV-infected T/NK cells, and the host immune response to infection, including the roles carried out by innate immunity and inflammatory cytokines, are likely to be revealed in the future. Copyright

AB - Epstein-Barr virus (EBV) is usually maintained in an asymptomatic and latent form by the host immune system, and primarily by EBV-specific cytotoxic T cells (CTLs). However, EBV has been linked to several refractory diseases such as EBV-associated hemophagocytic syndrome (EBV-AHS) and chronic active EBV infection (CAEBV). In these ectopic diseases, EBV infects T/NK cells, causing severe immunodeficiency with a very high EBV load. In recent years, the laboratory procedure to assess these types of EBV infections has been improved. In particular, real-time polymerase chain reaction (PCR) has been used to quantify the EBV load, and the MHC: peptide tetramer assay has been used to quantitate EBV-specific CTLs; these tests have been employed for the management of the illnesses associated with EBV infection. Here, we have reviewed the recent progress in the clinical application of these assays. The pathogenesis of EBV-infected T/NK cells, and the host immune response to infection, including the roles carried out by innate immunity and inflammatory cytokines, are likely to be revealed in the future. Copyright

KW - Chronic active Epstein-Barr virus infection

KW - Epstein-Barr virus-associated hemophagocytic syndrome

KW - Real-time PCR

KW - Tetramer

UR - http://www.scopus.com/inward/record.url?scp=31344478710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344478710&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 239

EP - 246

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 6

ER -